The 30 Best Clinical trials in Guilford, Connecticut

Tanya Bilchik, MD, located at 800 Boston Post Road in Guilford, Connecticut, is a reputable neurology institution specializing in the treatment of headaches. With over 25 years of experience, Dr. Bilchik offers a range of medications to manage severe migraines, helping patients improve their quality of life. She trained at Yale and in South Africa before establishing her headache practice in Hartford for over 15 years. Dr. Bilchik has been involved in various headache medication trials, including Botox Chronic Migraine study and CGRP monoclonal antibody trials for migraine prevention. The institution also provides treatment for rare neurological conditions like trigeminal neuralgia and movement disorders like dystonia. If you experience sensations like dizziness, the institution offers comprehensive care and treatment options.

Dr. Wajih Zaheer, MD is a renowned oncologist located at 111 Goose Lane in Guilford, Connecticut, United States. With over 17 years of experience, Dr. Zaheer has established a busy oncology practice that is considered one of the busiest on the shoreline. He follows national and hospital quality guidelines to provide state-of-the-art cancer care to his patients. Dr. Zaheer serves as the Medical Director of the office in Guilford, which transitioned to Yale Smilow Guilford in 2012. His dedication to patient care and quality has led to the expansion of services, including surgical and radiology services, as well as the opening of another office in Old Saybrook. He has collaborated with Radiation Oncology to develop a busy Breast Cancer program and is actively involved in clinical research through the Clinical Research Working Group.

Lajos Pusztai is a renowned institution located at 111 Goose Lane, Guilford, Connecticut, United States. Dr. Pusztai is a Professor of Medicine at Yale University and serves as the Scientific Co-Director of the Breast Center, as well as the Co-Director of the Cancer Center Genomics, Genetics, and Epigenetics Program. With a medical degree from Semmelweis University of Medicine in Budapest and a D.Phil. degree from the University of Oxford in England, Dr. Pusztai's research group has made significant contributions to the understanding of different molecular, clinical, and epidemiological characteristics of estrogen receptor-positive and negative breast cancers. Dr. Pusztai has been a pioneer in utilizing gene expression profiling for predicting chemotherapy and endocrine therapy sensitivity, as well as developing bioinformatics tools for personalized treatment strategies. He is the principal investigator of several clinical trials investigating new drugs, including immunotherapies for breast cancer. With over 250 scientific manuscripts published in high-impact medical journals, Dr. Pusztai is recognized as one of the top 1% most highly cited clinical investigators in medicine. Additionally, he serves as an Associate Editor of the Journal of National Cancer Institute and is a member of the Scientific Advisory Board of the Breast Cancer Research Foundation.

Wajih Kidwai, MD, located in Guilford, Connecticut, is a medical oncologist and the medical director of Smilow Cancer Center. Dr. Kidwai specializes in medical oncology/hematology, breast oncology, gastrointestinal oncology, and hematologic oncology. He values direct discussions with patients and finds joy in witnessing their improvement. The institution provides high-quality cancer care services, including surgical and radiology services in Guilford and Old Saybrook. Dr. Kidwai has developed a breast cancer program and is currently leading a clinical trial for metastatic HER-2-positive breast cancer. He is also involved in nutrition and exercise-related clinical trials for breast cancer patients, as well as smoking cessation and palliative care programs. Chemotherapy and dyspnea treatments are also offered at Wajih Kidwai, MD.

Andrea Silber is a renowned doctor specializing in medical oncology located at 111 Goose Lane in Guilford, Connecticut, United States. Dr. Silber serves as the Associate CEHE Director for Clinical Research and is the Medical Director and Physician Champion of the Centers for Disease Control/Connecticut Department of Public Health's 5-year provider supported grant at Yale New Haven Hospital called The Connecticut Cancer Screening Program (CCSP). She has designed the Comprehensive Breast Cancer Outreach and Support Program for Underserved Women, supported by the Breast Cancer Alliance of Greenwich. Dr. Silber has been recognized for her expertise in breast cancer among African American women and has supervised Community Health Educators since 1996. She is the principal investigator of the Avon-Pfizer Metastatic Breast Cancer Grants Program: Identify-Amplify-Unify, assisting organizations that provide information and services to help patients navigate the challenges of their disease. Dr. Silber also leads the novel program "Breast Cancer S.W.A.T. Team- We’ve got your back!" funded by the CT Health and Educational Facilities Authority (CHEFA) to assist economically disadvantaged breast cancer patients.